World journal of urology

Antimicrobial resistance and infection control

archives of disease in childhood

journal of infection in developing countries

bjgp open

Current urology

[1] Gaps in communication between different staff groups and older adult patients foster unnecessary antibiotic prescribing for urinary tract infections in hospitals: a qualitative translation approach.

[2] GPs' attitudes towards the diagnosis and treatment of male urinary tract infections: a qualitative interview study in Ireland.

[3] Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

[4] treinamento esfincteriano: métodos, expectativas dos pais e morbidades associadas toilet training: methods, parental expectations and associated dysfunctions

[5] spontaneous resolution of vesicoureteral reflux (vur) in iranian children, a single center experience in 533 cases

[6] pathogen distribution and drug resistance of nephrology patients with urinary tract infections

[7] antimicrobial susceptibility of community-acquired uropathogens in general practice

[8] infecciones tempranas en pacientes trasplantados en un hospital de alta complejidad

[9] susceptibility trends and molecular characterization of gram-negative bacilli associated with urinary tract and intra-abdominal infections in jordan and lebanon: smart 2011–2013

[10] virulence markers of vancomycin resistant enterococci isolated from infected and colonized patients

[11] urinary tract infection with pasteurella multocida in a patient with cat exposure and abnormal urinary tract physiology: case report and literature review

[12] caracterización clínica e imagenológica de niños y niñas con malformaciones urogenitales imaging and clinical characterization of children with urogenital malformations

[13] Uropathogens and Gestational Outcomes of Urinary Tract Infections in Pregnancies that Necessitate Hospitalization.

[14] Successful eradication of chronic symptomatic Candida krusei urinary tract infection with increased dose micafungin in a liver and kidney transplant recipient: Case report and review of the literature.

[15] Community acquired urinary tract infections among adults in Accra, Ghana

[16] Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection

[17] In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

[18] Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

[19] Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

[20] Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China

[21] Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections

[22] Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

[23] Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

[24] Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

[25] The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

[26] Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, Mozambique

[27] Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

[28] Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

[29] Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

[30] Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria

[31] Procalcitonin as a useful marker to decide upon intervention for urinary tract infection

[32] Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran

[33] Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections

[34] Community acquired urinary tract infections among adults in Accra, Ghana

[35] Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection

[36] In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

[37] Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

[38] Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

[39] Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China

[40] Community acquired urinary tract infections among adults in Accra, Ghana

[41] Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection

[42] In vitro effect of fosfomycin on multi-drug resistant gram-negative bacteria causing urinary tract infections

[43] Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy

[44] Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not – a retrospective cohort study

[45] Characterization of a NDM-7 carbapenemase-producing Escherichia coli ST410 clinical strain isolated from a urinary tract infection in China

[46] Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections

[47] Comparative study of antimicrobial resistance and biofilm formation among Gram-positive uropathogens isolated from community-acquired urinary tract infections and catheter-associated urinary tract infections

[48] Susceptibilities of Gram-negative bacilli from hospital- and community-acquired intra-abdominal and urinary tract infections: a 2016–2017 update of the Chinese SMART study

[49] Oral sitafloxacin vs intravenous ceftriaxone followed by oral cefdinir for acute pyelonephritis and complicated urinary tract infection: a randomized controlled trial

[50] Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study

[51] The prevalence of plasmid-mediated quinolone resistance and ESBL-production in Enterobacteriaceae isolated from urinary tract infections

[52] Epidemiology and molecular characterization of multidrug-resistant Escherichia coli isolates harboring blaCTX-M group 1 extended-spectrum β-lactamases causing bacteremia and urinary tract infection in Manhiça, Mozambique

[53] Extensively drug-resistant Myroides odoratimimus – a case series of urinary tract infections in immunocompromised patients

[54] Epidemiology, susceptibility, and risk factors for acquisition of MDR/XDR Gram-negative bacteria among kidney transplant recipients with urinary tract infections

[55] Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

[56] Antibiotic sensitivity pattern of uropathogens from pregnant women with urinary tract infection in Abakaliki, Nigeria

[57] Procalcitonin as a useful marker to decide upon intervention for urinary tract infection

[58] Demographic features and antibiotic resistance among children hospitalized for urinary tract infection in northwest Iran

[59] Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections

[60] Cholecalciferol for the prophylaxis against recurrent urinary tract infection among patients with benign prostatic hyperplasia: a randomized, comparative study.

[61] Reducing the incidence of pregnancy-related urinary tract infection by improving the knowledge and preventive practices of pregnant women.

[62] Does antimicrobial coating and impregnation of urinary catheters prevent catheter-associated urinary tract infection? A review of clinical and preclinical studies.

[63] Calcineurin inhibitor Tacrolimus impairs host immune response against urinary tract infection

[64] Gaps in communication between different staff groups and older adult patients foster unnecessary antibiotic prescribing for urinary tract infections in hospitals: a qualitative translation approach.

[65] Variable selection in covariate dependent random partition models: an application to urinary tract infection.

[66] Catheter-Associated Urinary Tract Infections in Adults: Diagnosis, Treatment, and Prevention.

[67] [An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections].

[68] [Single-dose amoxicillin, TMP-SMX and ofloxacin therapy in lower urinary tract infections].

[69] GPs' attitudes towards the diagnosis and treatment of male urinary tract infections: a qualitative interview study in Ireland.

[70] Failure of urinary beta-glucuronidase activity to localize the site of urinary tract infection

[71] Preventing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit.

[72] Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Enterobacteriaceae- related urinary tract infections.

[73] Urinary tract infections and affecting factors detected in tobb university of economics and technology faculty of medicine hospital: A 5-year retrospective study

[74] Extended Abstract: Multicenter Comparison of Safety and Efficacy of Cefprozil vs. Cefaclor in the Treatment of Acute and Uncomplicated Urinary Tract Infections

[75] Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

[76] A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections

[77] Use of Quinolones in Urinary Tract Infections and Prostatitis

[78] A single center observational study on emergency department clinician non-adherence to clinical practice guidelines for treatment of uncomplicated urinary tract infections

[79] Temporal Changes in the Prevalence of Community-Acquired Antimicrobial-Resistant Urinary Tract Infection Affected by Escherichia coli Clonal Group Composition

[80] An Approach to Evaluating Antibacterial Agents in the Treatment of Urinary Tract Infection

[81] Prevalence and predictors of urinary tract infection and severe malaria among febrile children attending Makongoro health centre in Mwanza city, North-Western Tanzania

[82] Prevalence and predictors of urinary tract infection and severe malaria among febrile children attending Makongoro health centre in Mwanza city, North-Western Tanzania

[83] nursing actions to prevent urinary tract infection associated with long-standing bladder catheter

[84] reliability and validity of a chinese version of urinary tract infection symptom assessment questionnaire

[85] evaluating children with otitis media for bacteremia or urinary tract infection

[86] urinary tract infection due to chryseobacterium gleum, an uncommon pathogen

[87] correlation between urine analysis and urine culture in the diagnosis of urinary tract infection in yazd central laboratory

[88] risk factors for postoperative urinary tract infections in patients undergoing total joint arthroplasty

[89] antimicrobial susceptibility patterns among escherichia coli urinary isolates from community-onset health care-associated urinary tract infection

[90] incidence and antibiotic susceptibility pattern of most common bacterial pathogen causing urinary tract infection (uti) in tehran, iran, 2012-2013

[91] complicated urinary tract infection caused by extended spectrum β-lactamase-producing escherichia coli

[92] bacteremic renal stone-associated urinary tract infection caused by nontypable haemophilus influenzae: a rare invasive disease in an immunocompetent patient

[93] cranberries for preventing urinary tract infections

[94] extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in são luís, brazil

[95] biofilm formation capability of enterococcal strains causing urinary tract infection vis-a-vis colonisation and correlation with enterococcal surface protein gene

[96] time-based distribution of staphylococcus saprophyticus pulsed field gel-electrophoresis clusters in community-acquired urinary tract infections

[97] high-throughput method for antibiotic susceptibility testing based on fluorescein quenching by bacteria: application to urinary tract infection

[98] antimicrobial resistance pattern of escherichia coli isolated from patients with urinary tract infection (uti) in yasuj city during 1391-1392.

[99] pathogen distribution and drug resistance of nephrology patients with urinary tract infections

[100] the tir domain containing locus of enterococcus faecalis is predominant among urinary tract infection isolates and downregulates host inflammatory response

[101] long-term efficacy of fulguration of trigonitis for recurrent urinary tract infections in women